Crossmark

Potential drug-drug interactions in patients with indication for prophylactic implantation of a cardioverter defibrillator: a cross-sectional analysis

Crossref DOI link: https://doi.org/10.1186/s12913-020-05131-7

Published Online: 2020-03-31

Published Print: 2020-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Dornquast, Christina

Dombrowski, Mirja

Zabel, Markus

Willich, Stefan N.

Reinhold, Thomas
Funding

Funding for this research was provided by:

Seventh Framework Programme (602299)

Bundesministerium für Bildung und Forschung (01EH1604B)
License Information

Text and Data Mining valid from 2020-03-31

Version of Record valid from 2020-03-31
More Information

Article History

Received: 3 December 2019

Accepted: 20 March 2020

First Online: 31 March 2020

Ethics approval and consent to participate

: This research has been approved by the Ethics Committee of the University Medical Center Göttingen/Germany and all participating centers. All patients gave their informed written consent prior to inclusion. The study is conducted in accordance with the Declaration of Helsinki and Good Clinical Practice (GCP) principles.

: Not applicable

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below